The upside does not require a heroic
rerating. Recent Army awards strengthen proof of demand across strike and
directed energy, while
AV Eagle and cross-sell from the broader portfolio can widen the installed base. If management turns that into steadier deliveries, better mix, and lower financing drag, investors can keep paying a premium defense-tech multiple.